Market Research

Psychedelic Invest is your source for the latest business and investing news about the burgeoning psychedelics industry.

Market Research

Psychedelic Stock Market Update August 2022: ETF Edition

In 2021, one of the leading stories for psychedelic stock investors was the introduction of ETFs focused on the burgeoning sector.  Here at Psychedelic Invest, we published multiple news alerts (here and here for example) and deep dives around the introduction of said ETFs.  But with the announcement from ETF provider Defiance last month that they would be shutting down their psychedelics focused ETF on August 30th, many investors began to fear that the hype around psychedelics was over.  But is it?  Obviously psychedelics have an important role to play in the future of mental health. To add, the industry…

Lifestyle

Psychedelic Analogues Solve The Problems Of Limiting Psychedelic Treatment Model

Traditional psychedelics have shown great potential for treating issues like depression, anxiety, PTSD, and addiction. Psilocybin and MDMA will likely be available for patients in the next couple of years with other psychedelic compounds like LSD and DMT following suit. Even if these compounds can significantly help those who have access to them, there are constraints on these traditional psychedelic compounds that make it hard to roll out widespread treatment options. A growing number of biotechnology companies are working on new compounds to help overcome the limitations of the currently known psychedelic compounds– these are called psychedelic analogues. In pharmacology,…

Lifestyle

Dreams, Psychedelics, and Their Linked Hallucinations

Psychedelics are known for encouraging the exploration of the subconscious, but what about the unconscious? Since the beginning of discussions about psychedelics in academic circles, research has been done to examine their potential and understand the interactions caused within the brain. This research has continually found that psychedelics have far more capabilities than many originally thought. However, one area of research that’s still being developed is how psychedelics affect sleep and more specifically, dreams. Learning more about this interaction is important, as it can provide more information about consciousness, brain chemistry, and mind-altering drugs. What Is Consciousness? Consciousness is a…

Interviews

VIDEO: Interview with Josh Bartch, CEO of Mydecine Innovations Group

Earlier this week, we published an article on Mydecine Innovations Group ($MYCO) and their recent changes, developments, and pivots. Following that publication, our very own Charley Rose sat down with the CEO of Mydecine, Josh Bartch. During the interview, Charley does a deep dive into the company and its current positioning in the market. For those that were still looking for more information on the company, this interview will shed the light you’re looking for. Browse More Videos on our YouTube Channel If you’d like to watch more interviews like this one, head over to our YouTube channel and like…

Lifestyle

Mydecine Repositions For A Successful Future

Mydecine Innovations Group ($MYCO) is a next-generation biotechnology company that is no stranger to headlines. From their inception in 2020, they have made quite a splash. Between their successful development of novel psychedelic compounds, their partnerships with major research institutions, and the acquisition of the successful technology platform Mindleap, Mydecine has shown great potential over the past couple of years. However, the company has had a string of press releases since April that have left people questioning whether the company will make it.  There is no shortage of articles making assumptions that the company is preparing to close its doors….